Today: 12 March 2026
Browse Category

NYSE:JNJ 15 January 2026 - 23 January 2026

Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson shares traded nearly flat at $218.59 by late Friday morning as Wall Street upgrades met renewed worries over federal talc lawsuits. A special master recommended allowing plaintiffs’ experts to testify that J&J talc products can cause ovarian cancer, affecting over 67,500 cases. The company reported Q4 sales up 9.1% to $24.6 billion and projected 2026 sales of up to $101 billion.
Johnson & Johnson stock price today: JNJ ends higher, but talc case stays in focus after earnings

Johnson & Johnson stock price today: JNJ ends higher, but talc case stays in focus after earnings

Johnson & Johnson closed up 0.3% at $218.49 Thursday after reporting Q4 revenue of $24.56 billion and adjusted earnings of $2.46 per share. The company projected 2026 sales above estimates but faces ongoing pressure from U.S. drug pricing, tariffs, and talc litigation. A court-appointed special master recommended allowing expert testimony in the New Jersey talc case. J&J plans to appeal.
Johnson & Johnson stock price rises today as investors weigh 2026 outlook — and talc lawsuit clock

Johnson & Johnson stock price rises today as investors weigh 2026 outlook — and talc lawsuit clock

Johnson & Johnson shares rose 1.1% to $220.36 Thursday after the company posted fourth-quarter sales of $24.564 billion and adjusted EPS of $2.46, beating forecasts. J&J projected 2026 adjusted EPS of $11.43–$11.63 and sales up to $101 billion. The company warned of a $500 million tariff hit and ongoing legal risks from talc lawsuits. Investors reacted to declining Stelara sales and competition in medical devices.
22 January 2026
Johnson & Johnson stock price swings late as JNJ guidance beats views, but talc risk grabs traders again

Johnson & Johnson stock price swings late as JNJ guidance beats views, but talc risk grabs traders again

Johnson & Johnson shares slipped 0.05% to $218.01 in after-hours trading Wednesday after the company projected 2026 sales and profits above Wall Street estimates. Investors weighed the upbeat forecast against renewed legal risks as a court-appointed special master recommended allowing expert testimony in federal talc litigation involving over 67,500 lawsuits. J&J plans to appeal the ruling.
Why Johnson & Johnson stock is slipping today after JNJ’s 2026 forecast

Why Johnson & Johnson stock is slipping today after JNJ’s 2026 forecast

Johnson & Johnson shares fell 1.3% to $215.31 after its 2026 outlook and Q4 results, as renewed legal risks and pricing pressures weighed on investors. The company reported Q4 sales of $24.564 billion and forecasted 2026 adjusted EPS of $11.43–$11.63. Legal pressure increased after a special master advised allowing expert testimony in talc cancer lawsuits. Tariff risks and Stelara's decline added to market concerns.
21 January 2026
Johnson & Johnson stock price slips after-hours ahead of earnings as tariff fears rattle markets

Johnson & Johnson stock price slips after-hours ahead of earnings as tariff fears rattle markets

Johnson & Johnson shares slipped 0.2% to $218.21 in after-hours trading Tuesday ahead of quarterly earnings due Wednesday. The move followed a broad market selloff, with the Dow down 1.76% and the S&P 500 off 2.06% after new U.S. tariff threats. Analysts expect Q4 profit of $2.47 per share. The company faces ongoing litigation, including a $1.5 billion verdict over talc products.
Dow Jones futures drop on Trump tariff threat as Wall Street sets up for Netflix, PCE week

Dow Jones futures drop on Trump tariff threat as Wall Street sets up for Netflix, PCE week

The Dow closed down 0.2% at 49,359.33 on Friday ahead of the MLK Day market holiday. Dow futures fell 0.7% after President Trump threatened a 10% tariff on imports from eight European nations tied to Greenland, with the rate set to rise to 25% in June if talks fail. European leaders condemned the move and gold hit new highs as investors sought safety. Traders await key earnings and Thursday’s PCE inflation data.
Trump’s Greenland tariff threat sets up a tense week for global stocks

Trump’s Greenland tariff threat sets up a tense week for global stocks

President Donald Trump threatened 10% tariffs on eight European countries tied to Greenland, escalating to 25% by June if no deal is reached. The S&P 500 closed nearly flat at 6,940.01, while the Dow and Nasdaq also posted slight losses. Europe’s STOXX 600 ended flat, and China’s regulator announced tighter market controls. U.S. markets will close Monday for Martin Luther King Jr. Day.
Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson shares closed down 0.4% at $218.66 Friday ahead of the Martin Luther King Jr. Day market holiday. The S&P 500 health care sector fell 0.8%. J&J reports fourth-quarter results Wednesday, Jan. 21, with investors focused on earnings and 2026 guidance. The NYSE will reopen Tuesday after the holiday.
Supreme Court Fed showdown, Davos and China GDP: what to watch in global markets next week

Supreme Court Fed showdown, Davos and China GDP: what to watch in global markets next week

The U.S. Supreme Court will hear arguments Wednesday on President Trump’s effort to remove Fed Governor Lisa Cook. Stocks ended the week lower, with the S&P 500 at 6,940.01 and Brent crude at $64.13. China releases GDP data as Davos opens, while Japan nears a possible snap election. Prime Minister Takaichi may suspend Japan’s 8% food sales tax, risking a 5 trillion yen revenue hit.
Johnson & Johnson stock slips — what traders watch before JNJ earnings

Johnson & Johnson stock slips — what traders watch before JNJ earnings

Johnson & Johnson shares closed down 0.41% at $218.66 Friday and were flat after hours. The company reports fourth-quarter earnings January 21, with investors watching for updates on drug approvals and MedTech growth. FDA fast-track reviews and consumer-health deals remain in focus. Kenvue, spun off from J&J, faces a key shareholder vote January 29 on its sale to Kimberly-Clark.
Johnson & Johnson stock rises after Tecvayli trial win as JNJ eyes earnings

Johnson & Johnson stock rises after Tecvayli trial win as JNJ eyes earnings

Johnson & Johnson shares rose 2.3% to $218.55 in after-hours trading Wednesday after reporting its Tecvayli drug cut the risk of disease progression or death by 71% in a late-stage multiple myeloma trial. An independent committee recommended unblinding the study. Full results will be presented at an upcoming medical meeting. Investors await the company’s quarterly results next week.
1 2 3 4 5 8

Stock Market Today

  • Sugar Prices Slip After Reaching Two-Month Peak Amid Surplus Concerns
    March 12, 2026, 4:13 AM EDT. Sugar prices declined on Wednesday, with May New York world sugar down 0.90% and May London ICE white sugar falling 1.15%. The retreat followed a two-month high on Monday and was driven by long liquidation and a slightly stronger dollar. Despite a 5% rally in oil prices, which often supports sugar by boosting ethanol production and reducing sugar supply, concerns about a persistent global sugar surplus weighed on the market. Multiple analysts and the International Sugar Organization project sugar surpluses ranging from 1.22 to 8.3 million metric tons for 2025-27, driven by increased output in countries like India, Thailand, and Pakistan. India, the world's second-largest sugar producer, raised export quotas amid higher production, pressuring prices further.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 12.03.2026

12 March 2026
LIVEMarkets rolling coverageStarted: March 12, 2026, 12:00 AM EDTUpdated: March 12, 2026, 4:13 AM EDT Sugar Prices Slip After Reaching Two-Month Peak Amid Surplus Concerns March 12, 2026, 4:13 AM EDT. Sugar prices declined on Wednesday, with May New York world sugar down 0.90% and May London ICE white sugar falling 1.15%. The retreat followed a two-month high on Monday and was driven by long liquidation and a slightly stronger dollar. Despite a 5% rally in oil prices, which often supports sugar by boosting ethanol production and reducing sugar supply, concerns about a persistent global sugar surplus weighed on the
XRP Price Today: Ripple’s Australia License Push Keeps XRP Near $1.40

XRP Price Today: Ripple’s Australia License Push Keeps XRP Near $1.40

11 March 2026
XRP traded near $1.40, down 1.4% Wednesday, after Ripple announced plans to acquire BC Payments Australia to secure an Australian Financial Services Licence. The move comes as Australia tightens licensing rules for digital-asset firms. Broader crypto markets remained cautious amid concerns over oil prices, Iran, and U.S. inflation. Ripple’s deal is pending completion.
Natural Gas Price Today: Europe Gas Holds Firm as Brussels Weighs Cap After Qatar Shock

Natural Gas Price Today: Europe Gas Holds Firm as Brussels Weighs Cap After Qatar Shock

11 March 2026
European natural gas prices held near 48 euros per megawatt hour Wednesday as Shell declared force majeure on Qatari LNG cargoes, with disruptions expected to hit from April. Asia is bidding up for replacement fuel, while Brussels considers subsidies or a price cap. LNG Canada increased shipments, but analysts warn Europe’s gas storage could end March far below average if Qatari supply issues persist.
Go toTop